Quick answer
Zurich Biotech ships lyophilized research peptides to Semarang and the wider Central Java region, typically within one to two business days. Semarang is Central Java's provincial capital and its main deep-water port, so shipments continue on to Kudus, Demak, Kendal, and Salatiga after clearing the city. BPOM Regulation No. 27 of 2022 (as amended by Regulation No. 8 of 2024) governs research-use imports of unregistered pharmaceuticals through the Special Access Scheme, and that framework applies in Semarang the same way it applies anywhere else in Indonesia.
BPOM and the regulatory framework for research imports
BPOM (Badan Pengawas Obat dan Makanan) is Indonesia's national drug and food regulator. Any pharmaceutical product without a domestic Marketing Authorization enters the country through a licensed channel. For research purposes, that channel is the Special Access Scheme (SAS), which covers research, clinical development, and other non-commercial scientific uses.
Research peptides are not classified as narcotics or psychotropics under Indonesian law, so they move through the standard SAS route. BPOM Regulation No. 8 of 2024, issued alongside Government Regulation No. 28 of 2024 implementing Law No. 17 of 2023 on Health, added a digital processing track that shortened turnaround time on SAS authorizations nationwide, Central Java included.
For a researcher receiving an order in Semarang, the SAS authorization sits with the importing entity, not the individual recipient. Orders ship with a Certificate of Analysis; the COA guide covers what to check against the batch on arrival.
Shipping to Semarang and Central Java
Tanjung Emas, Semarang's deep-water port, has handled the province's container and bulk cargo for decades. By 2026 it shares that role with the newer Kaliwungu terminal a short distance west in Kendal Regency, built to take vessels and volumes that Tanjung Emas's shallower berths cannot. Pharmaceutical cargo bound for the province still generally clears through Semarang's existing customs infrastructure before the final leg of delivery.
Semarang is also headquarters to PT Industri Jamu dan Farmasi Sido Muncul, one of Indonesia's largest herbal-medicine and pharmaceutical manufacturers. That gives the city an existing base of pharmaceutical logistics, quality control, and cold storage know-how that overlaps with the requirements for handling peptide shipments.
Same-day or next-day delivery covers the city proper: Tembalang, Candisari, Banyumanik, and the old town district around Kota Lama. Orders to Ungaran, Demak, and Kendal in the immediate metro area arrive within one to two business days. Shipments continuing on to Kudus, Pati, or Salatiga typically add a day, since they ride the same courier network rather than a dedicated line.
Climate and storage requirements in Semarang
Semarang sits in ICH Climatic Zone IVb, the hot-and-very-humid classification that sets accelerated pharmaceutical stability testing at 30 degrees C and 75% relative humidity. The city's own averages run close to that benchmark: daytime highs near 32 degrees C year-round, with relative humidity ranging from around 64% in the drier months of July through September to nearly 88% during the November through May rainy season.
Lyophilized peptide picks up ambient moisture once a vial is opened to air under these conditions. A 2015 study on a lyophilized formulation of secretin, a peptide hormone used as a model compound, published in the International Journal of Pharmaceutics (Srinivasan et al., Int J Pharm 2015), recorded measurable chemical degradation and visible particulate formation in material held at elevated temperature and humidity, tracked through X-ray powder diffraction and thermal analysis. Semarang's ambient humidity sits above dry, climate-controlled storage conditions for most of the year, which is the case for keeping vials sealed and refrigerated rather than left on a bench.
Vials should go into a freezer at -20 degrees C or colder as soon as they arrive. A multi-site consensus on peptide handling for mass-spectrometry assays, published in Clinical Chemistry (Hoofnagle et al., Clin Chem 2016), recommends storage between -20 and -80 degrees C for anything held longer than a year. The same paper tested peptide samples through up to 10 freeze-thaw cycles and found no statistically significant drop in peak area compared to continuously refrigerated controls, though the authors still recommend minimizing freeze-thaw events as routine practice. A standard lab or household freezer set to -18 degrees C or below covers most research timelines of six to twelve months.
Reconstituted peptide belongs in the refrigerator at 2 to 8 degrees C between uses, not on a bench at room temperature. Grid power in central Semarang is generally stable; outlying districts toward Kendal and Demak see more frequent short outages during the rainy season, so a small UPS on the storage freezer is worth the cost. Full guidance on freeze-thaw limits and desiccant use is in the article on lyophilized peptide storage in tropical climates.
Research environment in Semarang
Diponegoro University (UNDIP) is Central Java's largest research university, with more than 7,700 Scopus-indexed documents on record, ranking seventh nationally by that measure. Its pharmacy program sits within the Faculty of Medicine rather than as a standalone pharmacy faculty, based on the university's main campus in Tembalang alongside its medical and health science programs.
RSUP Dr. Kariadi, UNDIP's teaching hospital in Semarang, was one of seven hospital sites nationwide, alongside Jakarta, Surabaya, Yogyakarta, Makassar, Denpasar, and Medan, in the TRIPOD tuberculosis drug-resistance cohort study, run jointly by Indonesia's National Institute of Health Research and Development and the U.S. National Institute of Allergy and Infectious Diseases. The study enrolled 490 patients nationwide between 2017 and 2021, with Dr. Kariadi contributing part of that total. Trial infrastructure at that scale gives Semarang clinical research capacity beyond what a provincial capital of its size typically carries.
Research peptides ordered in Semarang
Orders from Semarang follow a similar compound mix to Jakarta and Surabaya, skewing toward tissue-repair and metabolic research. BPC-157 and TB-500 account for the largest share, drawing from both university-affiliated researchers and independent labs. The city's existing pharmaceutical manufacturing base, anchored by Sido Muncul, means Semarang already carries more cold-chain and quality-control infrastructure in daily commercial use than most Central Java cities its size.
Retatrutide order volume has grown faster than any other compound over the past year, in line with the national trend as more researchers track the Phase 3 data on the triple GLP-1/GIP/glucagon agonist. For reconstitution and dosing math on any compound shipped to Semarang, the peptide dosing calculator handles the volume and concentration calculations for standard vial sizes and U-100 syringes.